FI  Schooner Capital

http://www.schoonercapital.com





     Office Locations:

60 South Street, Suite 1120
Boston, MA 02111
Phone: 617-963-5200
Fax: 617-963-5201

 

Stages:

  • Early


 

Industries:

  • Information Technology
  • Software & Internet

  •  

    Description:

    Founded in 1971, Schooner Capital, LLC is a private investment firm managing approximately $300 million. A family office headed by Vin Ryan, Schooner has no outside limited partners and approaches all investments with a long-term perspective. Ryan served as a Director of Iron Mountain (1971-2015), a $10+ billion global records management company which he purchased and grew from a single storage site. Areas of concentration for Schooner are growth equity investments, alternative assets, and public securities. The firm focuses on U.S.-based companies. The firm also invests in hedge funds, private equity funds, venture capital funds, and other specialized alternative asset structures across sectors and across the globe. In 1996, Vin created The Schooner Foundation, which supports a number of not-for-profit causes globally, with a particular emphasis on human rights. Vin currently serves as a Director of the Nature Conservancy and served as a Director of the Marine Biological Laboratory, the Isabella Stewart Gardner Museum, Physicians for Human Rights, and Survivor Corps.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alexandra Manick Associate Principal
    Antonio Cienfuegos Associate Principal
    Emily Caccam Operations and Foundation Associate
    Jon Corbett Vice President
    Julia Pettengill Executive Director

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      07/10/2024


      MANTLE


      CA


      $20,000,000


      Series C


      05/31/2024


      Brixton Biosciences


      MA


      $33,000,000


      Series B


     

    Portfolio companies include:

     

    Recent News: